Company ThermoGenesis Holdings, Inc.

Equities

THMO

US88362L2097

Office Equipment

Market Closed - Nasdaq 04:30:00 2024-05-22 pm EDT 5-day change 1st Jan Change
0.6063 USD +1.05% Intraday chart for ThermoGenesis Holdings, Inc. -6.72% +0.88%

Business Summary

ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.

Number of employees: 25

Sales per Business

USD in Million2022Weight2023Weight Delta
Device- Automated Cell Separation System
52.6 %
6 56.4 % 5 52.6 % -15.92%
Device- Automated Cryopreservation System
15.7 %
1 11.9 % 1 15.7 % +19.01%
Service- Automated Cryopreservation System
14.4 %
1 9.2 % 1 14.4 % +40.60%
Other- X-Series
8.2 %
0 2.7 % 1 8.2 % +173.33%
Device- Other
3.0 %
0 0.6 % 0 3.0 % +350.00%
Service- Automated Cell Separation System
2.5 %
0 4.6 % 0 2.5 % -51.67%
Service- X-Series
1.6 %
0 1.8 % 0 1.6 % -20.00%
Device- X-Series
1.3 %
1 6.2 % 0 1.3 % -81.50%
Other
0.6 %
0 0.3 % 0 0.6 % +100.00%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
63.8 %
7 63.4 % 6 63.8 % -9.22%
Other
26.7 %
1 7.6 % 3 26.7 % +216.17%
United Arab Emirates
6.0 %
-- 1 6.0 % -
Vietnam
2.4 %
1 4.9 % 0 2.4 % -56.31%
China
1.0 %
2 18.9 % 0 1.0 % -95.06%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 16-03-09
Director of Finance/CFO 51 09-12-31
Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 17-02-23
Director/Board Member 78 17-01-09
Chief Executive Officer 53 16-03-09
Director/Board Member 53 16-11-02
Director/Board Member - 23-07-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,952,780 3,512,481 ( 44.17 %) 0 44.17 %

Shareholders

NameEquities%Valuation
4,440,279 55.83 % 3 M $
Raymond James & Associates, Inc.
0.8174 %
65,004 0.8174 % 44 203 $
Vanguard Group, Inc. (Subfiler)
0.4454 %
35,419 0.4454 % 24 085 $
Virtu Financial LLC
0.3326 %
26,451 0.3326 % 17 987 $
Citadel Securities GP LLC
0.2036 %
16,195 0.2036 % 11 013 $
Geode Capital Management LLC
0.1293 %
10,284 0.1293 % 6 993 $
Morgan Stanley Capital Services LLC
0.1169 %
9,295 0.1169 % 6 321 $
Tower Research Capital LLC
0.0914 %
7,266 0.0914 % 4 941 $
UBS Securities LLC
0.0857 %
6,817 0.0857 % 4 636 $
BlackRock Institutional Trust Co. NA
0.0188 %
1,492 0.0188 % 1 015 $

Company contact information

ThermoGenesis Holdings, Inc.

2711 Citrus Road

95742, Rancho Cordova

+916 858 5100

http://www.thermogenesis.com
address ThermoGenesis Holdings, Inc.(THMO)
  1. Stock Market
  2. Equities
  3. THMO Stock
  4. Company ThermoGenesis Holdings, Inc.